June 9, 2011 – Integrating & Sustaining Clinical Research

pearl header

Indiana Hospital Association andPearl IRB invite you to a webinar:Integrating and Sustaining Clinical Research

June 9, 2011 from 3:00 – 4:30 P.M. EST.

Register Here

 

Featured Presentations

  • Clinical Research: Why Get Involved and How to Do It Right by Gretchen Bowker
  • Sharing Lessons Learned in Building Research Capabilities at One Institution by Robert Plant
  • A Sponsor’s Perspective: What We Look for in a Good Clinical Trial Site by Kara Mezger

During this webinar, you’ll learn:

  • Multiple benefits of clinical research
  • Tactics and operational tips to help start or improve your research program
  • How to plan a practical approach to meet federal regulations as well as identifying characteristics that attract research sponsors to your practice or organization
  • The best practices of successful clinical research programs and review common pitfalls to avoid

 

This webinar will benefit CEOs, CNOs, physician practice management leaders, IRB administrators or board members, private practice site administrators, and research site personnel.

Registration Fee: $200 per site registration (includes one phone connection and one internet connection for unlimited participants in the same location)

To learn more, click here.

 

About Pearl IRB

Pearl IRB is an independent Institutional Review Board that provides comprehensive IRB services for sponsors, institutions, principal investigators, and CRO’s nationwide.We deliver quality and timely reviews that balance the interests of human subjects, sponsors, and institutions. Together, we will drive enhanced efficiency and value in clinical research.To learn more, please visit us atwww.pearlirb.com, call us at 317.278.4100, or emailinfo@pearlirb.com.

IHA Logo
WEBINAR

 

Integrating and Sustaining Clinical Research

 

June 9, 2011

3:00- 4:30 P.M. EST

Register Now

Featured Speakers Gretchen Bowker-the chief operating officer for Pearl IRB. She has over 25 years experience in the development of pharmaceuticals, biologics, and devices and is a recognized expert in regulatory issues, bioethics, and compliance. Gretchen has over 15 years experience at both Eli Lilly and Roche Diagnostics.

Kara Mezgerthe associate director of clinical affairs at Zimmer and a seasoned device development leader. At Zimmer, Kara has led a team of clinical researchers that supports all clinical research activities and regulatory support documents for 510k class I-II and PMA devices.

Robert Plant – the director of the Parkview Hospital Research Center in Ft. Wayne. He serves Parkview Community Hospital, primary investigators, and sponsors by conducting high quality research programs. Robert has worked with large sponsors such as St. Jude Medical, Sanofi-Aventis, Merck, Genentech, Astra Zeneca, and Medtronic to deliver high quality clinical trials which have resulted in dozens of new innovations being launched into the marketplace.

 

Need assistance with an IRB review or clinical trials?

Contact Us 

Check out our Website and Blog atwww.pearlirb.com

 

Enhanced by Zemanta

May 18, 2011 – FDA Regulatory 101

Indiana Medical Device Manufacturers Council 2011 FDA Regulatory 101 Course

May 18, 2011

CLE Credits Requested

Presented by a host of Indiana Medical Device Manufacturing Sector Experts:

4 Sponsorships Available

(Sponsorship includes promotions, signage at the event as well as a shared table for materials distribution. Sign up at the bottom of the Registration Form)

Program Agenda

Bios

8:00-8:30 am. Registration / Continental Breakfast / Networking
8:30-9:00 Welcome/Overview Ralph Hall, Counsel, 

Baker & Daniels

 

9:00-9:45 Clinical Trials and IDEs 

 

Keli Hankee, Manager, Clinical Affairs, 

Biomet, Inc.

9:45-10-00 Break 

 

10:00-11:00 Submissions Colleen Hittle, Managing Partner 

The Anson Group

11:00-11:30 Combination Products Suzanne O’Shea, Partner 

Baker & Daniels

 

11:30-12:00 Complaint Handling/Adverse Event Reporting 

 

Laura Lyons, VP, Clinical, Quality & Regulatory Affairs, 

SonarMed

12:00-1:15 Lunch and Networking  

 

1:15-1:45 Corrections and Removals Chris Kilander, Regulatory Manager/ Corporate Compliance Administrator 

Cook Urological, Inc

1:45-2:30 QSR Overview Richeal Cline, Quality Director, 

Roche Diagnostics (invited)

2:30-3:15 Advertising and Promotional Controls Danelle Miller, Regulatory Counsel 

Roche Diagnostics

 

3:15-3:30 Break 

 

3:30-4:00 Enforcement Ralph Hall, Counsel 

Baker & Daniels

4:00-4:30 Emerging Trends and Panel Q&A Panel of Prior Speakers

Register Online Now!

Registration:  8:00 am

Program 8:30 – 4:30 pm

Location:  Montage Catering Facility, 8580 Allison Pointe Blvd., Indianapolis, IN 46250

 

Members: $195 per person
(Member discounts apply when registering more than 4 attendees at the same time)

Non-Members: $275 per person

Location: Montage, 8580 Allison Pointe Blvd., Indianapolis, IN 46250  Get directions

For more information:

Contact: Blake Jeffery
Phone: 317-951-1388
Email: IMDMCoffice@ameritech.net

 

Enhanced by Zemanta

November 6, 2010 – Pearl IRB Speaking at the ACRP Excellence in Clinical Research Fall Symposium

Pearl IRB is speaking on a panel and exhibiting at the ACRP Excellence in Clinical Research Fall Symposium – REGISTER NOW!
Don’t miss the Circle City ACRP Event
held on November 6, 2010

Who should attend:

All personnel who are involved in or planning to be involved in clinical research. This conference is targeted for both new and experienced clinical research professionals including research nurses, clinical research coordinators, investigators, site managers, IRB members, and Pharmaceutical & Medical Device representatives.

What will be covered:

The pursuit of excellence in clinical research will be presented from the perspective of each of the major clinical research stakeholders. Click here for full agenda and brochure.

Date:   November 6, 2010

Time:  7:30am – 4:30pm

Where:  Indianapolis, Indiana at the downtown University Place Hotel

Register now!

This Event Has Been Approved for 7.5 Contact Hours

About Pearl IRB

Pearl IRB is an independent Institutional Review Board that provides comprehensive IRB services for institutions, principal investigators, and CRO’s nationwide.We deliver quality and timely reviews that balance the interests of human subjects, sponsors, and institutions. Together, we will drive enhanced efficiency and value in clinical research.To learn more, please visit us at www.pearlirb.com, call us at 317.278.4100, or email info@pearlirb.com.

Enhanced by Zemanta

July 25 2010 – American Association for Clinical Chemistry Annual Meeting

AACC Annual Meeting

July 25, 2010
Anaheim, CA

http://www.aacc.org

Sponsored by: American Association for Clinical Chemistry

Contact: custserv@aacc.org / 202-857-0717

Enhanced by Zemanta

May 24 & 25, 2010 – Clinical Trial Design For Medical Devices

Clinical Trial Design For Medical Devices

Who Should Attend

This two-day course is designed:

  • Device Manufacturers
  • Device Sponsors and Management
  • Clinical Laboratory Administrators, Directors, and Managers
  • HealthCare Professionals
  • CROs
  • Project Managers

Learning Objectives

The objective of this course is to provide an overview of the preparation, design and management aspects of clinical trials for medical devices.  Upon completion of this course, attendees will have an understanding of the unique challenges faced in clinical trials for medical devices, which will be useful in the future development of device technology.

This course will review challenges, roles and responsibilities of sponsors and investigators during the clinical development phase.  Participants will learn the essentials of coordinating, monitoring, and managing a clinical trial with an emphasis on good quality product outcome and meeting ICH E6 for Good Clinical Practice.

Register Now.

Reblog this post [with Zemanta]

April 23-27, 2010 – ACRP Global Conference and Exhibition 2010

ACRP Global Conference and Exhibition 2010

The goal of the conference is to enhance the knowledge and skills of conference attendees in the conduct of clinical trials in order to evaluate the drug, biologic, and/or medical device’s safety and effectiveness in treating, preventing or diagnosing a specific disease or condition. In addition to providing clinical research education and training, this conference acknowledges the dedication and excellence of its membership.

Register here.

Reblog this post [with Zemanta]

March 25, 2010 – ASQ Biomedical Midwest discussion group meeting

ASQ Biomedical Midwest discussion group meeting

What is the difference?  How do they affect us?  Why do we have them?  Click on the link and get registered today to find out more!!!

NEW REGISTRATION PROCESS: Get registered today!

Come hear Fred McClure, currently Manager, Regulatory Compliance at Roche in Indianapolis, IN and responsible for recalls in the US.

Fred has 12 years of regulatory experience in Medical Devices.  He spent 5 years in orthopedic implant industry and 7 years in the in-vitro diagnostic industry.  He has a breadth of experience in the medical device regulatory field including experience in pre-market regulatory submissions (510(k), PMA and IDE), clinical trials, post market activities (complaint handling, medical device reporting and recalls), quality system management, internal auditing, supplier auditing, FDA 483 and Warning Letter remediation as well as review and approval of advertising and promotional materials.

Reblog this post [with Zemanta]

April 15, 2010 – IHIF Clinical Networking April Reception

IHIF Clinical Networking April Reception

Hosted by Clarian and Methodist Research Institute

Mark April 15th in your calendars for more than just Tax Day! Clarian / Methodist Research Institute (MRI), Indiana Health Industry Forum (IHIF) and Baker & Daniels are hosting a networking reception for members of the IHIF Clinical Trials Working Group and invited VIP guests.

Speaker Anantha Shekhar, M.D, Chair of the Indiana Clinic Research Committee and Director of the Indiana Clinical and Translational Sciences Institute, will address how the emergence of the Indiana Clinic will positively affect and impact research in Indiana. Cary Mariash, M.D., Medical Director of the Methodist Research Institute and a practicing physician at Indiana Clinic Endocrinology, will also be on hand to answer questions.

Date: Thursday, April 15, 2010
Time: 5:00 p.m. - 6:30 p.m. EDT

Methodist Research Institute
1812 North Capitol Avenue
Indianapolis, IN 46202

Register here.

Reblog this post [with Zemanta]

January 11 – 12, 2010 – Medical Device Clinical Research & Reimbursement Conference

Medical Device Clinical Research

& Reimbursement Conference

Understanding the Complex Nature of Conducting Medical Device Studies that Support Regulatory and Reimbursement Goals in a Cost and Time Effective Manner

January 11-12
Phoenix, Arizona

About the Conference

This conference program will bring together executives from industry to discuss and debate the challenges that they face in designing and conducting studies that support an increasing array of corporate goals. Keynote presentations will address topics of interest to clinical and reimbursement executives, on movements within the industry resulting in new evidence thresholds, as well as methods for bringing teams together throughout the product lifecycle to ensure targets are met.

Each afternoon, the audience will divide into break-out sessions that will focus more specifically on topics related to clinical research or reimbursement

Topics to Include:

General Sessions

  • Understanding the Impact of Changes in Health Policy on Evidence Requirements for Medical Devices
  • Comparative Effectiveness Studies Impacting Medical Devices
  • Understanding Coding Principles from the Clinical Research Perspective

Clinical Study Breakouts

  • Optimizing Site Selection through working with Sales, Marketing and KOL’s
  • Ethical and IRB Considerations in Subject Enrollment
  • Understanding Pathways for Working with FDA to Secure Device Approval
  • Opportunities in Post-Marketing Clinical Research

Reimbursement Breakouts

  • Developing End points to Support Reimbursement in Post-Marketing Studies
  • Preparing for and Understanding Health Technology Assessments
  • Recognizing Differing Evidence Requirements for Private vs. Public Payers
Reblog this post [with Zemanta]

Indy Medical Device Compnay FAST Diagnostics Receives Federal Grant

Reposted from Manufacturing & Technology eJournal:

FAST Diagnostics, a developer of a technology for the rapid assessment of kidney function has received additional federal funding to further develop and validate its device technologies.

The company, which is based in the Indiana University Emerging Technologies Center on the IUPUI campus, is using a $1 million Phase II Small Business Technology Transfer grant from the National Institutes of Health for further development and trials of its early detection technology. Grant procurement assistance was provided by the state’s SBIR/STTR office. FAST Diagnostics is also a 2008 recipient of a $2 million grant from the state’s 21st Century Research and Technology Fund.

Read the entire article . . .

Reblog this post [with Zemanta]